Similarly, cooperativity between XIAP inhibitors and TRAIL resulted in a strong apoptotic response in pancreatic carcinoma or leukemia cells, capable to even overcome a Bcl-2-mediated resistance [51,52]. Here, TNFSF10 is linked to exocrine pancreatic carcinoma.